Related Experiment Video
Updated: Feb 22, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Rheumatoid arthritis and citrullination
1Division of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Dysregulated citrullination, a key feature of rheumatoid arthritis (RA), involves citrullinating enzymes (peptidylarginine deiminases, PADs). Factors like calcium, redox conditions, and pore-forming proteins contribute to PAD hyperactivation and citrullination in RA.
Area of Science:
- Rheumatology
- Immunology
- Biochemistry
Background:
- Rheumatoid arthritis (RA) is characterized by antibodies to citrullinated proteins.
- Citrullination, the modification of arginine residues to citrulline, is central to RA pathogenesis.
Purpose of the Study:
- To review recent literature on the origins of citrullinated antigens in rheumatoid arthritis.
- To explore the mechanisms driving dysregulated citrullination in RA.
Main Methods:
- Review of current scientific literature on citrullination in RA.
- Analysis of findings from studies on synovial fluid in RA patients.
Main Results:
- The RA citrullinome, comprising citrullinated proteins in the RA joint, has been identified.
- Mechanisms controlling the generation of citrullinated proteins in RA have been elucidated.
- Dysregulated citrullination occurs both intracellularly and extracellularly in RA.
Conclusions:
- Peptidylarginine deiminases (PADs) are tightly regulated, with calcium and redox conditions influencing their activity.
- Neutrophil activation by pore-forming proteins leads to calcium influx, cytolysis, and PAD hyperactivation, driving hypercitrullination.
- Extracellular citrullination in RA may involve the release of active PADs from dying cells and acceleration by autoantibodies.
More Related Videos
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
11:03A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model
Published on: October 30, 2019
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Rheumatic Heart Disease III: Medical Management
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...